Testing a new drug in healthy men after a meal
Part of Kidney & urinary clinical trials.
This trial compares two versions of a drug to see if they work the same in the body when taken with food. Healthy adult male volunteers are needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy man aged 19 or older
- You weigh at least 110 pounds (50 kg)
- Your body mass index (BMI) is between 18 and 30
- You have not been in another drug study in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two new experimental drugs (AD-116 and AD-1161) in healthy adult men to see how safe they are and how the body processes them. If you are a healthy man who meets the weight and age criteria, you may be able to join.
This trial tests whether two versions of a drug, AD-116A and AD-1161, are equally effective and safe in the body. Healthy adult male volunteers take the drug and have their blood levels compared.
This trial compares how the body processes two different forms of the same drug, AD-117 and AD-117A, and checks for safety. It's for healthy adults to help ensure the drug works similarly and safely.
This trial tests a new drug (AD-115A or AD-1151) in healthy volunteers to see how safe it is and how the body processes it. If you qualify, you'll receive a single dose and be monitored closely.
This trial tests whether three experimental drugs (AD-231A, AD-231B, and AD-231C) interact with each other and how safe they are. Healthy volunteers are needed to help understand how the body processes these drugs.
This study tests two new experimental drugs, AD-118 and AD-1181, in healthy adults to see if they are safe and how the body processes them. It helps researchers decide if further testing in patients is possible.
Hear when a new Benign Prostatic Hyperplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.